Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mekinist
Mekinist
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Endpoints
Sun, 03/19/23 - 01:36 pm
Novartis
Tafinlar
Mekinist
pediatric
brain cancer
FDA
Genuv Cancer Drug Shows Early Potential in Alzheimer's
BioSpace
Thu, 08/18/22 - 11:19 pm
Genuv
Alzheimer's disease
Mekinist
Novartis Combo could be New Standard of Care for Pediatric Glioma Patients
BioSpace
Wed, 06/8/22 - 10:42 am
Novartis
Tafinlar
Mekinist
pediatric
clinical trials
glioma
ASCO 2022
FDA approves Novartis combo therapy for aggressive type of thyroid cancer
Reuters
Fri, 05/4/18 - 06:53 pm
Novartis
FDA
Tafinlar
Mekinist
anaplastic thyroid cancer
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
Mon, 10/23/17 - 09:57 am
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Fri, 06/23/17 - 03:35 pm
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer
Fierce Pharma
Wed, 04/5/17 - 12:07 pm
Novartis
Europe
Tafinlar
Mekinist
lung cancer
BRAF V600
Novartis' Lung Cancer Drug Combo Gets EU Nod
Investopedia
Mon, 04/3/17 - 09:19 am
Novartis
Europe
metastatic non-small cell lung cancer
Tafinlar
Mekinist
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Tue, 09/1/15 - 06:35 pm
Novartis
Europe
melanoma
GSK
Mekinist
Tafinlar
Novartis melanoma drug combination wins EU green light
Yahoo/Reuters
Sat, 07/25/15 - 09:38 am
Novartis
melanoma
Europe
Mekinist
Tafinlar
GSK
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Wed, 05/27/15 - 11:26 am
Novartis
R&D
cancer
Tafinlar
Mekinist
GSK
ASCO
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Tue, 11/18/14 - 11:51 am
Clovis
GSK
non-small cell lung cancer
Mekinist
rociletinib
Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma
First Word Pharma
Thu, 07/17/14 - 10:12 am
GSK
Mekinist
Tafinlar
Zelboraf
melanoma
EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar
Yahoo/Reuters
Fri, 04/25/14 - 11:02 am
GSK
melanoma
Europe
Bayer
Nexavar
Mekinist
thyroid cancer
GSK melanoma drug combination faces delay in Europe
Yahoo/Reuters
Wed, 03/26/14 - 08:01 am
GSK
Europe
melanoma
Mekinist
Tafinlar
GlaxoSmithKline and Personalized Medicine Take Another Leap Forward
Motley Fool
Mon, 01/27/14 - 12:18 pm
GSK
personalized medicine
melanoma
Tafinlar
Mekinist
Merck
GSK says melanoma combination meets main goal
Reuters
Fri, 01/24/14 - 12:15 pm
GSK
Tafinlar
Mekinist
melanoma
GSK melanoma drug combination wins accelerated U.S. approval
Yahoo/Reuters
Thu, 01/9/14 - 08:37 am
GSK
FDA
Tafinlar
Mekinist
melanoma
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
3 Orphan Drugmakers to Watch
Motley Fool
Wed, 10/23/13 - 08:43 am
orphan drugs
Biomarin
GSK
Vimizim
Tafinlar
Mekinist
Myozyme
Cerazyme
Sanofi
Pages
1
2
next ›
last »